"Curiosity breeds innovation."
Shan Chung is currently a Director and Principal Scientist in the Department of BioAnalytical Sciences (BAS), gRED. Shan received his Ph.D. in Molecular Biology from University of Pennsylvania and completed his postdoctoral training in Protein Engineering at Harvard University. Shan has more than 20 years’ experience in research and development of pharmaceutical products, specifically in the areas of preclinical and clinical development of therapeutic antibodies. An expert on Fc effector functions, bioanalytical assays, and immunogenicity of biotherapeutics, Shan serves on the USP Fc Function Expert Panel, and is an active member of the AAPS Working Group on Immunogenicity Risk Assessment and Mitigation. Shan joined Genentech in 2006, and currently leads the Effector Function and Cell Biology group in BAS.
I enjoy the opportunity to work with postdocs on exploratory/research projects which often adds additional excitement and innovation to my work.
J. Immunol Methods 468:55-60.
J Immunol Methods, 407: 63–75.
The responsibilities of my group include biological characterization of clinical candidates, development and validation of bioanalytical assays, and evaluation of immunogenicity potential and pharmacokinetics liability of antibody products.